Table 5

Estimates to genotype relative risk at rs6983267, 9q22, and rs944289

LocusNon-carriersHeterozygousHomozygous carriers
Population frequencyORPopulation frequencyORPopulation frequency
rs6983267*0.236NANA1.2740.272
9q220.3152.3850.3224.4550.074
rs9442890.1641.3090.4781.7550.358
Combined0.0123.1220.2109.9610.017
  • * rs69833267 heterozygous do not have increased risk of thyroid cancer (see tables 1 and 4).

  • ORs and frequencies for the 9q22 markers were obtained from the diplotype analysis presented in table 3. Population frequency from non-carriers, heterozygous and homozygous carriers is shown in table 3.